Qun Zhao Selected Research

benzylparaben

7/2022

Toxic effects of waterborne benzylparaben on the growth, antioxidant capacity and lipid metabolism of Nile tilapia (Oreochromis niloticus).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Qun Zhao Research Topics

Disease

74	Neoplasms (Cancer) 04/2022 - 11/2002
50	Stomach Neoplasms (Stomach Cancer) 03/2022 - 10/2004
16	Carcinoma (Carcinomatosis) 10/2020 - 09/2003
14	Adenocarcinoma 01/2022 - 05/2013
13	Inflammation (Inflammations) 10/2022 - 03/2011
11	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2014
10	Lymphatic Metastasis 01/2019 - 09/2003
9	Colitis 10/2020 - 05/2015
8	Carcinogenesis 01/2021 - 03/2008
6	Infections 12/2022 - 11/2016
6	Developmental Dysplasia of the Hip 03/2022 - 08/2010
5	Colonic Neoplasms (Colon Cancer) 07/2021 - 09/2015
5	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 01/2019
4	Cardiovascular Diseases (Cardiovascular Disease) 05/2022 - 04/2006
4	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2019
4	Fibrosis (Cirrhosis) 01/2021 - 01/2013
4	Lung Diseases (Lung Disease) 05/2020 - 03/2005
4	Body Weight (Weight, Body) 01/2020 - 12/2011
4	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2019 - 12/2013
4	Congenital Abnormalities (Deformity) 11/2016 - 03/2007
3	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 12/2016
3	Hypoxia (Hypoxemia) 01/2022 - 01/2015
3	Gliosis 01/2022 - 09/2015
3	Anemia 01/2021 - 06/2015
3	Acquired Immunodeficiency Syndrome (AIDS) 01/2017 - 03/2009
2	Necrosis 01/2022 - 01/2020
2	Lung Injury 01/2022 - 12/2013
2	Squamous Cell Carcinoma of Head and Neck 11/2021 - 08/2015
2	Margins of Excision 08/2021 - 09/2014
2	Iron Overload 01/2021 - 11/2018
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 10/2020 - 01/2016
2	Ovarian Epithelial Carcinoma 09/2020 - 10/2008
2	Hypertension (High Blood Pressure) 03/2019 - 11/2018
2	Myocardial Infarction 11/2018 - 01/2015
2	Leukemia 12/2017 - 04/2016
2	Disease Progression 11/2017 - 11/2011

Drug/Important Bio-Agent (IBA)

38	Proteins (Proteins, Gene)FDA Link 01/2022 - 09/2003
9	Oxaliplatin (Eloxatin)FDA LinkGeneric 03/2022 - 08/2010
9	CytokinesIBA 02/2020 - 01/2006
8	Vitamin D FDA LinkGeneric 10/2020 - 08/2010
7	Capecitabine (Xeloda)FDA Link 03/2022 - 05/2013
7	Fluorouracil (Carac)FDA LinkGeneric 07/2021 - 10/2004
7	Biomarkers (Surrogate Marker)IBA 01/2021 - 10/2008
6	XELOXIBA 03/2022 - 05/2013
6	Messenger RNA (mRNA)IBA 01/2022 - 05/2015
6	Phosphotransferases (Kinase)IBA 01/2022 - 01/2006
6	Biological ProductsIBA 01/2018 - 12/2007
5	Long Noncoding RNAIBA 01/2022 - 07/2017
5	celastrol methyl esterIBA 11/2021 - 01/2019
5	Annexin A7 (Synexin)IBA 01/2020 - 01/2014
5	MicroRNAs (MicroRNA)IBA 01/2019 - 05/2015
5	Pharmaceutical PreparationsIBA 01/2016 - 11/2002
4	TriterpenesIBA 11/2021 - 01/2019
4	apatinibIBA 08/2021 - 09/2020
4	Calcitriol Receptors (Calcitriol Receptor)IBA 10/2020 - 05/2015
4	Small Interfering RNA (siRNA)IBA 01/2020 - 02/2014
4	Cisplatin (Platino)FDA LinkGeneric 06/2018 - 12/2009
4	Losartan (Cozaar)FDA LinkGeneric 02/2016 - 08/2010
3	RNA (Ribonucleic Acid)IBA 03/2022 - 09/2015
3	CarbonIBA 01/2022 - 10/2021
3	Paclitaxel (Taxol)FDA LinkGeneric 08/2021 - 06/2018
3	Oncogene Proteins (Oncogene Protein)IBA 04/2021 - 04/2016
3	OxazoloneIBA 08/2020 - 01/2016
3	Angiotensin IIIBA 02/2016 - 12/2013
3	ferric oxide (iron oxide)IBA 01/2015 - 05/2011
3	SurvivinIBA 01/2013 - 11/2010
3	trioctyl phosphine oxide (TOPO)IBA 01/2013 - 01/2010
2	SuspensionsIBA 01/2022 - 01/2022
2	Trastuzumab (Herceptin)FDA Link 01/2022 - 01/2021
2	Imatinib Mesylate (Gleevec)FDA Link 01/2022 - 11/2017
2	Therapeutic UsesIBA 06/2021 - 08/2010
2	InflammasomesIBA 06/2021 - 09/2017
2	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 05/2021 - 01/2021
2	human ERBB2 proteinIBA 04/2021 - 01/2021
2	CarcinogensIBA 04/2021 - 08/2015
2	hydroxide ionIBA 01/2021 - 01/2013
2	ErbB Receptors (EGF Receptor)IBA 01/2021 - 01/2021
2	ChemokinesIBA 01/2021 - 05/2015
2	Interleukin-6 (Interleukin 6)IBA 01/2021 - 03/2012
2	neo-gambogic acidIBA 11/2020 - 12/2016
2	Dextran SulfateIBA 10/2020 - 01/2020
2	AntigensIBA 06/2020 - 02/2020
2	CateninsIBA 01/2020 - 01/2019
2	Cyclin D1IBA 01/2020 - 03/2015
2	Proliferating Cell Nuclear Antigen (PCNA)IBA 01/2020 - 03/2015
2	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2020 - 01/2010
2	Indicators and Reagents (Reagents)IBA 01/2019 - 05/2017
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2018 - 09/2015
2	celastrolIBA 09/2017 - 04/2016
2	Carrier Proteins (Binding Protein)IBA 04/2017 - 05/2013

Therapy/Procedure

21	Therapeutics 12/2022 - 11/2002
17	Neoadjuvant Therapy 03/2022 - 05/2013
13	Drug Therapy (Chemotherapy) 03/2022 - 10/2004
5	Gastrectomy 01/2022 - 05/2015
4	Chemoradiotherapy 03/2021 - 06/2015
3	Lymph Node Excision (Lymph Node Dissection) 01/2022 - 07/2013
3	Osteotomy 01/2012 - 08/2010
2	Immunotherapy 03/2022 - 11/2011
2	Blood Transfusion (Blood Transfusions) 01/2021 - 12/2017
2	Duration of Therapy 01/2019 - 11/2018